![David Zaccardelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Zaccardelli
Chairman at
SAB BIOTHERAPEUTICS, INC.
Net worth: - $ as of 2026-08-30
Profile
David S.
Zaccardelli is the founder of Bull City Select Investments LLC.
Current positions include Chairman at SAB Biotherapeutics, Inc. starting in 2026, Director at Elucida Oncology, Inc. since 2021, Director at Evecxia, Inc. since 2016, and Independent Director at Vor Biopharma, Inc. starting in 2026.
Former roles include Chief Executive Officer & Director at Cempra, Inc. from 2016 to 2017, President, Chief Executive Officer & Director at Dova Pharmaceuticals, Inc. from 2018 to 2019, President, CEO & Executive Director at Verona Pharma Ltd. from 2020 to 2025, Director at CoreRx, Inc. from 2015 to 2021, Director-Clinical & Scientific Affairs at Bausch & Lomb Pharmaceuticals, Inc. from 1996 to 1997, Independent Director at Melinta Therapeutics, Inc. from 2016 to 2020, and Chief Operating Officer & Executive Vice President at United Therapeutics Corp.
from 2015 to 2016.
Education includes a doctorate from the University of Michigan conferred in 1988.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VOR BIOPHARMA, INC. -.--% | 2026-07-06 | 0 ( -.--% ) | - $ | 2026-08-30 |
David Zaccardelli active positions
| Companies | Position | Start |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Chairman | 2026-01-04 |
| VOR BIOPHARMA INC. | Director/Board Member | 2026-07-05 |
Evecxia, Inc.
 Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Director/Board Member | 2016-05-31 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Director/Board Member | 2021-04-28 |
Bull City Select Investments LLC
 Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Founder | - |
Former positions of David Zaccardelli
| Companies | Position | End |
|---|---|---|
CoreRx, Inc.
 CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of solid, liquid & semi-solid dosage forms | Director/Board Member | 2020-12-31 |
| MELINTA THERAPEUTICS, INC. | Director/Board Member | 2020-04-19 |
| DOVA PHARMACEUTICALS, INC. | Chief Executive Officer | 2019-11-11 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Chief Executive Officer | 2017-10-31 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of David Zaccardelli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of solid, liquid & semi-solid dosage forms | Commercial Services |
Bausch & Lomb Pharmaceuticals, Inc.
 Bausch & Lomb Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets eye health products | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Bull City Select Investments LLC
Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
- Stock Market
- Insiders
- David Zaccardelli
